Target intelligence / Profile preview

Uropathogenic Escherichia coli flagellar apparatus (UPEC flagellum) (UPEC flagellum)

Target
UPEC flagellum
Molecular classification
Protein complex, Molecular motor, Other
01

Overview

The Uropathogenic Escherichia coli (UPEC) motility apparatus is a complex, multi-protein nanomachine, primarily composed of the bacterial flagellum, that facilitates movement through the urinary tract (PubMed: 22237503). It consists of three main parts: a basal body that acts as a rotary motor, a universal joint (hook), and a long helical filament made of flagellin (FliC) (UniProt: P06179). This apparatus is essential for UPEC virulence, allowing the bacteria to ascend from the bladder to the kidneys, thereby causing pyelonephritis and potentially entering the bloodstream (PubMed: 15557271). Beyond locomotion, the motility apparatus is involved in chemotaxis, biofilm formation, and initial adhesion to host cells (PubMed: 21930716). Because motility is a key virulence factor, it is a target for "anti-virulence" therapies that aim to disarm the pathogen without exerting the strong selective pressure for resistance associated with traditional antibiotics (PubMed: 30254114). Experimental inhibitors have been designed to target the MotA/MotB stator complex or disrupt the assembly of the flagellar filament (PubMed: 28808611). These strategies focus on reducing the ability of UPEC to colonize and persist within the host environment, representing a shift toward precision medicine in treating infectious diseases.

Other names
Uropathogenic Escherichia coli motility apparatusUPEC motility systemBacterial flagellumFlagellar motorFlagellar filamentFliC complex
02

Mechanism of action

Inhibition of flagellar motor rotation, disruption of flagellar assembly, or inhibition of flagellin expression (PubMed: 30254114, PubMed: 28808611).

03

Biological functions

Bacterial motilityAdhesionBiofilm formationOther
04

Disease associations

Infection
05

Safety considerations

Impact on commensal microbiotaPotential for resistance developmentTherapeutic delivery to the urinary tract
06

Interacting drugs

Phenamil (experimental)

2 more in the full profile.

07

Biomarkers

Flagellin (FliC) expression levelsBacterial motility assaysUPEC titer in urine

Beyond the preview

Go deeper on Uropathogenic Escherichia coli flagellar apparatus (UPEC flagellum) (UPEC flagellum).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Uropathogenic Escherichia coli flagellar apparatus (UPEC flagellum) (UPEC flagellum).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call